
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recurrence-Free Survival in Patients With Surgically Resected Non-Small Cell Lung Cancer
Ravi Rajaram, Qing Huang, Richard Z. Li, et al.
CHEST Journal (2023) Vol. 165, Iss. 5, pp. 1260-1270
Open Access | Times Cited: 11
Ravi Rajaram, Qing Huang, Richard Z. Li, et al.
CHEST Journal (2023) Vol. 165, Iss. 5, pp. 1260-1270
Open Access | Times Cited: 11
Showing 11 citing articles:
Exploring Inflammatory Parameters in Lung Cancer Patients: A Retrospective Analysis
Cătălin Vlăduț Ionuț Feier, Călin Muntean, Alaviana Monique Faur, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 552-552
Open Access | Times Cited: 8
Cătălin Vlăduț Ionuț Feier, Călin Muntean, Alaviana Monique Faur, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 552-552
Open Access | Times Cited: 8
Do Right in the Left (Chest): Considering the Role of Adjunct Left Atrial Appendage Ligation During Lung Cancer Resection
Zachary DeBoard, Nishith Patel
Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery (2025)
Closed Access
Zachary DeBoard, Nishith Patel
Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery (2025)
Closed Access
Promising Utility of P21-Activated Kinase 4 Expression in the Prediction of Recurrence in Patients with Early-stage Non-small Cell Lung Cancer
Yosra Abdelmonem Zamzam, Yomna Zamzam, Ayman Mohamed Elsaka, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2025) Vol. 9, Iss. 1, pp. 87-92
Open Access
Yosra Abdelmonem Zamzam, Yomna Zamzam, Ayman Mohamed Elsaka, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2025) Vol. 9, Iss. 1, pp. 87-92
Open Access
The Lung Cancer Immune Prognostic Score predicts pathologic complete response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy
Yuyan Xie, Zhihao Shi, Tong Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yuyan Xie, Zhihao Shi, Tong Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
ERS Congress 2024: highlights from the Thoracic Surgery and Lung Transplantation Assembly
Dorina Esendağlı, Maria Giovanna Mastromarino, Álvaro Zúñiga, et al.
ERJ Open Research (2025) Vol. 11, Iss. 1, pp. 01046-2024
Open Access
Dorina Esendağlı, Maria Giovanna Mastromarino, Álvaro Zúñiga, et al.
ERJ Open Research (2025) Vol. 11, Iss. 1, pp. 01046-2024
Open Access
Prognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules
Renée Manser, Reem Malouf, Corynne Marchal, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Renée Manser, Reem Malouf, Corynne Marchal, et al.
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing
Kyeryoung Lee, Zongzhi Liu, Qing Huang, et al.
JCO Clinical Cancer Informatics (2025), Iss. 9
Closed Access
Kyeryoung Lee, Zongzhi Liu, Qing Huang, et al.
JCO Clinical Cancer Informatics (2025), Iss. 9
Closed Access
Thorax‐encompassing multi‐modality PET/CT deep learning model for resected lung cancer prognostication: A retrospective, multicenter study
Jaryd R. Christie, Perrin E. Romine, Karen Eddy, et al.
Medical Physics (2025)
Open Access
Jaryd R. Christie, Perrin E. Romine, Karen Eddy, et al.
Medical Physics (2025)
Open Access
Real-World Clinical Characteristics, Treatment Patterns, and Clinical Outcomes in US Patients with Stage I–III Resected NSCLC Without Known EGFR Mutations: The RESECT Study
Jhanelle E. Gray, R. Salomonsen, I. Diaz Perez, et al.
Drugs - Real World Outcomes (2025)
Open Access
Jhanelle E. Gray, R. Salomonsen, I. Diaz Perez, et al.
Drugs - Real World Outcomes (2025)
Open Access
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
Katharina Sinn, Adel Elbeialy, Berta Mosleh, et al.
Translational Oncology (2024) Vol. 51, pp. 102153-102153
Open Access
Katharina Sinn, Adel Elbeialy, Berta Mosleh, et al.
Translational Oncology (2024) Vol. 51, pp. 102153-102153
Open Access
Serum autoantibody-based biomarkers for prognosis in early-stage lung cancer patients with surgical resection
Panpan Jiang, Kaili Wang, Yaqin Wei, et al.
Research Square (Research Square) (2024)
Closed Access
Panpan Jiang, Kaili Wang, Yaqin Wei, et al.
Research Square (Research Square) (2024)
Closed Access
Global trends and research hotspots in perioperative management of lung cancer: a bibliometric analysis from 2004 to 2024
Qinling Jiang, Zhiqiang Wei, Pingping Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Qinling Jiang, Zhiqiang Wei, Pingping Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Association between forced expiratory volume in 1 s and relapse-free survival in operable non-small cell lung cancer: a prospective cohort study with propensity score overlap weighting
Shaoping Wu, Siqian Fu, Jeffrey W. Ripley-Gonzalez, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e085076-e085076
Open Access
Shaoping Wu, Siqian Fu, Jeffrey W. Ripley-Gonzalez, et al.
BMJ Open (2024) Vol. 14, Iss. 12, pp. e085076-e085076
Open Access